Letter: inflammatory bowel disease services during the Covid-19 pandemic
- PMID: 35362136
- PMCID: PMC9111189
- DOI: 10.1111/apt.16841
Letter: inflammatory bowel disease services during the Covid-19 pandemic
Abstract
This article is linked to Deputy et al papers. To view these articles, visit
Conflict of interest statement
Authors cannot pay for any charge and ask for full waiving for this correspondence.
Comment in
-
Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply.Aliment Pharmacol Ther. 2022 Apr;55(8):1064. doi: 10.1111/apt.16884. Aliment Pharmacol Ther. 2022. PMID: 35362132 Free PMC article.
Comment on
-
The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.Aliment Pharmacol Ther. 2022 Apr;55(7):836-846. doi: 10.1111/apt.16800. Epub 2022 Feb 7. Aliment Pharmacol Ther. 2022. PMID: 35132663 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical